Unique Plan Description: Tolvaptan (Samsca)
Plan Selection Display: Tolvaptan (Samsca)
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2015-04-13 10:09:49
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2025-03-11 15:06:30
Available at all facilities: Yes

Tolvaptan (Samsca)
Laboratory
	Basic Metabolic Panel
		T;N, Stat, spec type = Blood
			Comment: If not obtained in previous 4 hours
		T;N+360, Q6H, 24, hr, spec type = Blood
		T+2;0400, Q24H, spec type = Blood
Medications
		Restricted to use by Cardiology for clinically significant hypervolemic and uvolemic hyponatremia (Na+<125mEq/L) or symptomatic hyponatremia that resists correction with fluid restriction including HF and SIADH.(NOTE)*
	tolvaptan
		15 mg, Tab, By Mouth, DAILY, 4 Day(s)
			Comment: Discontinue therapy if sodium increases >8mEq/24hr or >14mEq/48hr or if sodium is > 135mEq/L.
Patient Care
	Neurological Assessment-Focused
		T;N, Q8H-Sch

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase